Amniotic fluid antibody titers and other prognostic parameters in erythroblastosis.
D000371:Agglutination; D000653:Amniotic Fluid / Q000032:analysis*; D000906:Antibodies / Q000032:analysis*; D000917:Antibody Formation; D001663:Bilirubin / Q000097:blood; D003298:Coombs Test; D004899:Erythroblastosis, Fetal / Q000175:diagnosis* / Q000276:immunology; D005163:Factor Analysis, Statistical; D005260:Female; D006801:Humans; D005779:Immunodiffusion; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000276:immunology*; D012204:Rh-Hr Blood-Group System; D013053:Spectrophotometry
D000906:Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D012204:Rh-Hr Blood-Group System; D001663:Bilirubin